Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance.
- NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_assertion description "[Semaphorin 3E is aberrantly expressed in prostate cancer and affects adhesion and motility of prostate cancer cells, indicating a role for the Sema3E/PlexinD1 signaling pathway in prostate cancer and identifying a new possible target for therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance.
- NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_assertion evidence source_evidence_literature NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance.
- NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_assertion SIO_000772 20949546 NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance.
- NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_assertion wasDerivedFrom befree-2016 NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance.
- NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_assertion wasGeneratedBy ECO_0000203 NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance.
- befree-2016 importedOn "2016-02-19" NP845865.RAPg-XrchD4V2UIi-D3PxQPnwFOP5TqiVFFmz_QiKD3SU130_provenance.